[HT-06] ホットトピックス06 New diagnostic and therapy strategies for PSP/CBD

[HT-06-3] PSPおよびCBD生体脳におけるタウ病変の可視化

^○樋口 真人 (量子科学技術研究開発機構)

Makoto Higuchi performed nuclear medicine research including clinical PET imaging in 1993 - 1997 and was awarded a Ph.D. in medicine at Tohoku University. He was appointed Assistant Professor of Geriatrics at Tohoku University in 1999 and worked as a postdoctoral research fellow at the University of Pennsylvania in 1999 - 2003. In 2003, he became Staff Scientist at RIKEN Brain Science Institute. He was appointed Team Leader at Molecular Imaging Center, National Institute of Radiological Sciences in 2005, and Department Head at National Institutes for Quantum and Radiological Science and Technology in 2019.
Dr. Higuchi’s primary research focus is translational molecular imaging on Alzheimer’s, Parkinson’s, and diverse other neuropsychiatric diseases bidirectionally connecting animal models and humans. His research accomplishments are represented by the development of imaging agents for pathological tau protein deposits in neurodegenerative disorders (Neuron 2013, 2020).